Smokers (n=17 ) | Non-Smokers (n=22 ) | p | |
---|---|---|---|
Age (y) | 30.0 ± 5.8 | 29.1 ± 6.4 | 0.65 |
Female/Male | 11/6 | 16/6 | |
Atopy (%) | 15 (88) | 21 (95) | |
Duration of asthma (y) | 19.2 ± 9.6 | 15.9 ± 8.8 | 0.28 |
N. pack-years of smoking | 10.9 ± 5.5 | ||
FEV1(L) | 3.2 ± 0.7 | 3.0 ± 0.7 | 0.31 |
% pred | 92.7 ± 16.7 | 85.1 ± 12.5 | 0.11 |
FVC (L) | 4.7 1.0 | 4.0 0.9 | 0.03 |
% pred | 116.1 ± 16.2 | 98.8 ± 13.9 | 0.001 |
PEF am (L/min) | 401.0 ± 65.4 | 417.3 ± 86.1 | 0.52 |
PEF pm (L/min) | 434.8 ± 70.1 | 432.2 ± 98.5 | 0.93 |
PC20 mg/ml* | 0.84 (0.51-1.38) | 0.85 (0.54-1.32) | 0.90 |
β2 use/week | 8.2 ± 3.6 | 4.5 ± 3.6 | 0.003 |
Awakenings/week | 1.8 ± 2.9 | 1.4 ± 2.7 | 0.66 |
Asthma episodes/week | 8.6 ± 5.6 | 6.8 ± 3.3 | 0.21 |
ACQ Score | 2.0 ± 0.6 | 1.9 ± 0.7 | 0.77 |
ACSS Score | |||
Clinical | 70.0 ± 9.5 | 73.2 ± 11.6 | 0.36 |
Physiological | 84.7 ± 13.3 | 81.8 ± 20.4 | 0.62 |
Inflammatory | 69.3 ± 24.9 | 62.9 ± 25.8 | 0.50 |
Global | 74.9 8.9 | 73.9 13.0 | 0.77 |
AQLQ Score | |||
Symptoms | 4.4 ± 1.0 | 4.3 ± 1.0. | 0.65 |
Activities | 5.6 ± 0.9 | 5.1 ± 1.2 | 0.16 |
Emotion | 5.1 ± 1.1 | 5.1 ± 1.3 | 0.91 |
Stimuli | 5.1 ± 1.2 | 5.1 ± 1.4 | 0.91 |
Global | 5.0 ± 0.8 | 4.8 ± 1.0 | 0.58 |